Chronic Phase Ph+ Chronic Myeloid Leukemia
1 clinical trials · Condition
◉ Watch Chronic Phase Ph+ Chronic Myeloid Leukemia
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Dose Redution of Radotinib as a First Line Treament in Ph+ CML (NCT06665412) | Il-Yang Pharm. Co., Ltd. | 2024-10-24 |
Track Chronic Phase Ph+ Chronic Myeloid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.